{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:07:48Z","timestamp":1782590868267,"version":"3.54.5"},"reference-count":46,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"accepted":{"date-parts":[[2022,12,11]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Hypotony is a well-recognised, sight-threatening complication of uveitis. It can also be the final common endpoint for a multitude of disease entities. Multiple mechanisms underlie hypotony, and meticulous clinical history alongside ocular phenotyping is necessary for choosing the best intervention and therapeutic management. In this narrative review, a comprehensive overview of medical and surgical treatment options for the management of non-surgically induced hypotony is provided. Management of ocular hypotony relies on the knowledge of the aetiology and mechanisms involved. An understanding of disease trajectory is vital to properly educate patients. Both anatomical and functional outcomes depend on the underlying pathophysiology and choice of treatment.<\/jats:p>","DOI":"10.1136\/bjo-2022-322814","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T18:20:17Z","timestamp":1671560417000},"page":"1765-1770","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Hypotony in uveitis: an overview of medical and surgical management"],"prefix":"10.1136","volume":"107","author":[{"given":"Ilaria","family":"Testi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Calcagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Petrushkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"2024110109351142000_107.12.1765.1","unstructured":"Pederson JE . Ocular Hypotony. In: Ritch RS , Shields MB , Krupin T , eds. The glaucomas. 2nd ed. St. Louis, Mosby, 1996: 385e95."},{"key":"2024110109351142000_107.12.1765.2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.survophthal.2019.04.006","article-title":"Ocular hypotony: a comprehensive review","volume":"64","author":"Wang","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"2024110109351142000_107.12.1765.3","unstructured":"Jampel HD . Reporting post-operative complications in glaucoma surgical trials. In: Shaarawy TMS , Sherwood MB , Grehn F , eds. Guidelines on design and reporting of glaucoma surgical trials. Amsterdam, the Netherlands: Kugler Publications, 2009: 33e9."},{"key":"2024110109351142000_107.12.1765.4","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2011.647228"},{"key":"2024110109351142000_107.12.1765.5","doi-asserted-by":"publisher","DOI":"10.2174\/1874364101004010052"},{"key":"2024110109351142000_107.12.1765.6","unstructured":"Millar C , Kaufman PL . Aqueous humor: secretion and dynamics. In: Tasman W , Jaeger EA , eds. Duane\u2019s foundations of clinical ophthalmology. Philadelphia: Lippincott-Raven, 1995."},{"key":"2024110109351142000_107.12.1765.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.08.001"},{"key":"2024110109351142000_107.12.1765.8","unstructured":"Gabelt BT , Kaufman PL . Aqueous humor hydrodynamics. In: Hart WM , ed. Adler\u2019s Physiology of the Eye. 9th. St. Louis: MO: Mosby, 2003."},{"key":"2024110109351142000_107.12.1765.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2009.06.005"},{"key":"2024110109351142000_107.12.1765.10","doi-asserted-by":"publisher","DOI":"10.1007\/BF02169204"},{"key":"2024110109351142000_107.12.1765.11","first-page":"477","article-title":"Aqueous humor dynamics in experimental iridocyclitis","volume":"28","author":"Toris","year":"1987","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024110109351142000_107.12.1765.12","first-page":"220","article-title":"Ocular hypotony","volume":"105","author":"Pederson","year":"1986","journal-title":"Trans Ophthalmol Soc U K"},{"key":"2024110109351142000_107.12.1765.13","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/ijo.IJO_1313_21","article-title":"Ultrasound biomicroscopy as a tool in the evaluation and management of ocular hypotony in uveitis","volume":"70","author":"Ganesh","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"2024110109351142000_107.12.1765.14","article-title":"Steroid-Induced glaucoma: an avoidable irreversible blindness","volume":"11","author":"Phulke","year":"2017","journal-title":"J Curr Glaucoma Pract"},{"key":"2024110109351142000_107.12.1765.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.01.033"},{"key":"2024110109351142000_107.12.1765.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2008.06.019"},{"key":"2024110109351142000_107.12.1765.17","article-title":"Intraocular pressure response in patients with hypotony and uveitis after intravitreal fluocinolone acetonide implantation (RetisertTM)","volume":"50","author":"Hebson","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2024110109351142000_107.12.1765.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2004.00319.x"},{"key":"2024110109351142000_107.12.1765.19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s004170100293","article-title":"Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony","volume":"239","author":"Jonas","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2024110109351142000_107.12.1765.20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.oret.2019.05.030","article-title":"Dexamethasone intravitreal implant injection in eyes with comorbid hypotony","volume":"3","author":"Kong","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"2024110109351142000_107.12.1765.21","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ajo.2011.04.035","article-title":"Pars plana vitrectomy, fluocinolone acetonide implantation, and silicone oil infusion for the treatment of chronic, refractory uveitic hypotony","volume":"152","author":"Dayani","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"2024110109351142000_107.12.1765.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-022-00284-4","article-title":"Keratoprosthesis, silicone oil placement, and fluocinolone acetonide implant for treatment of uveitis-associated hypotony and keratopathy","volume":"12","author":"Mosenia","year":"2022","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2024110109351142000_107.12.1765.23","doi-asserted-by":"publisher","DOI":"10.1007\/BF00917989"},{"key":"2024110109351142000_107.12.1765.24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00212960","article-title":"Increase in aqueous humor production following D1 receptors activation by means of ibopamine","volume":"20","author":"Virno","year":"1996","journal-title":"Int Ophthalmol"},{"key":"2024110109351142000_107.12.1765.25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00212961","article-title":"Topical ibopamine and corticosteroids in the treatment of post-surgery ocular hypotony","volume":"20","author":"Virno","year":"1996","journal-title":"Int Ophthalmol"},{"key":"2024110109351142000_107.12.1765.26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/112067210001000411","article-title":"Ibopamine treatment in chronic hypotony secondary to long-lasting uveitis. A case report","volume":"10","author":"Pivetti-Pezzi","year":"2000","journal-title":"Eur J Ophthalmol"},{"key":"2024110109351142000_107.12.1765.27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ajo.2005.09.034","article-title":"Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma","volume":"141","author":"Ugahary","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"2024110109351142000_107.12.1765.28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/IAE.0b013e3182265177","article-title":"Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma","volume":"32","author":"Ganteris-Gerritsen","year":"2012","journal-title":"Retina"},{"key":"2024110109351142000_107.12.1765.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.07.002"},{"key":"2024110109351142000_107.12.1765.30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/10807680151125393","article-title":"Ocular complications of latanoprost in uveitic glaucoma: three case reports","volume":"17","author":"Sacc\u00e0","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"2024110109351142000_107.12.1765.31","first-page":"408","article-title":"Uveitis-induced refractory ocular hypotony managed with high-dose latanoprost","volume":"15","author":"Ghassemi","year":"2020","journal-title":"J Ophthalmic Vis Res"},{"key":"2024110109351142000_107.12.1765.32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00137655","article-title":"Inflow and outflow relations after intraocular fluid-Healon exchange in a case of chronic ocular hypotension","volume":"8","author":"Koerner","year":"1985","journal-title":"Int Ophthalmol"},{"key":"2024110109351142000_107.12.1765.33","first-page":"236","article-title":"Management of severe hypotony with intravitreal injection of healon","volume":"28","author":"Cadera","year":"1993","journal-title":"Can J Ophthalmol"},{"key":"2024110109351142000_107.12.1765.34","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.ajo.2005.06.019","article-title":"Management of severe hypotony with intravitreal injection of viscoelastic","volume":"140","author":"Tosi","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"2024110109351142000_107.12.1765.35","first-page":"435","article-title":"Inhibition of phagocytosis by high molecular weight hyaluronate","volume":"40","author":"Forrester","year":"1980","journal-title":"Immunology"},{"key":"2024110109351142000_107.12.1765.36","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.143834"},{"key":"2024110109351142000_107.12.1765.37","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307799"},{"key":"2024110109351142000_107.12.1765.38","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.12275"},{"key":"2024110109351142000_107.12.1765.39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/IAE.0b013e31819a5fd8","article-title":"Successful outcome of pars plana vitreous surgery in chronic hypotony due to uveitis","volume":"29","author":"Gupta","year":"2009","journal-title":"Retina"},{"key":"2024110109351142000_107.12.1765.40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.eye.6701425","article-title":"The surgical management of chronic hypotony due to uveitis","volume":"19","author":"de Smet","year":"2005","journal-title":"Eye"},{"key":"2024110109351142000_107.12.1765.41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/IAE.0b013e3181b32f06","article-title":"Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection","volume":"30","author":"Kapur","year":"2010","journal-title":"Retina"},{"key":"2024110109351142000_107.12.1765.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00347-002-0716-8"},{"key":"2024110109351142000_107.12.1765.43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00006982-199717040-00009","article-title":"The artificial iris diaphragm for vitreoretinal silicone oil surgery","volume":"17","author":"Thumann","year":"1997","journal-title":"Retina"},{"key":"2024110109351142000_107.12.1765.44","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300983"},{"key":"2024110109351142000_107.12.1765.45","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00417-016-3364-4","article-title":"Intraocular silicone implant to treat chronic ocular hypotony-preliminary feasibility data","volume":"254","author":"Bayoudh","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2024110109351142000_107.12.1765.46","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00417-017-3714-x","article-title":"Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial","volume":"255","author":"Bayoudh","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjo-2022-322814","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T16:59:55Z","timestamp":1730739595000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjo-2022-322814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,11,22]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/bjo-2022-322814"],"URL":"https:\/\/doi.org\/10.1136\/bjo-2022-322814","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}